Macrophage polarization to M1 phenotype

Macrophage polarization to the M1 phenotype refers to the process by which monocyte-derived macrophages adopt a classically activated, pro-inflammatory functional state in response to specific environmental cues such as microbial products or cytokines, primarily interferon-gamma (IFN-γ) and lipopolysaccharide (LPS)[1][3][5][7][9]. M1 macrophages release high levels of pro-inflammatory cytokines and chemokines, possess strong pathogen-killing abilities (including phagocytosis), and promote Th1-type immune responses[1][3][4][5][6][7][8][9]. M1 polarization is governed by signaling pathways including IFN-γ receptor/JAK/STAT1, TLR4/MyD88/NF-κB, and is marked by upregulation of CD80, CD86, MHC II, and iNOS[1][4][5]. This phenotype is crucial for early host defense and pathogen clearance but excessive, chronic polarization can fuel inflammatory and autoimmune diseases, and also impact cancer and neurodegenerative conditions[3][4][6][9]. Important Note: Macrophage polarization to the M1 phenotype is NOT a molecule or receptor, but rather describes a biological process or cell state. Therefore, it cannot be considered a therapeutic target in the conventional molecular sense (like a receptor or enzyme), though drugs may modulate the signaling pathways leading to M1/M2 polarization[1][2][5][8][9].

Other names

M1 macrophage polarizationClassically activated macrophagePro-inflammatory macrophage polarization

Activation of pro-inflammatory signaling via TLR agonists (e.g., LPS); Stimulation by cytokines (e.g., IFN-γ, GM-CSF); Agonism or antagonism of relevant transcription factors (STAT1, NF-κB)